Citigroup Maintains Buy on Medtronic, Lowers Price Target to $110

Benzinga Newsdesk www.benzinga.com Negative 74.1%

Neg 74.1% Neu 0% Pos 0%

Citigroup analyst Joanne Wuensch maintains Medtronic (NYSE:MDT) with a Buy and lowers the price target from $117 to $110.